ARS Pharmaceuticals, Inc. (SPRY)
5.89
-0.14
(-2.32%)
USD |
NASDAQ |
Aug 28, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals 30-Day Average Daily Volume : 2.257M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 2.257M |
| August 27, 2026 | 2.288M |
| August 26, 2026 | 2.291M |
| August 25, 2026 | 2.314M |
| August 24, 2026 | 2.320M |
| August 21, 2026 | 2.302M |
| August 20, 2026 | 2.307M |
| August 19, 2026 | 2.275M |
| August 18, 2026 | 2.302M |
| August 17, 2026 | 2.278M |
| August 14, 2026 | 2.232M |
| August 13, 2026 | 2.124M |
| August 12, 2026 | 2.096M |
| August 11, 2026 | 2.097M |
| August 10, 2026 | 2.099M |
| August 07, 2026 | 2.222M |
| August 06, 2026 | 2.419M |
| August 05, 2026 | 2.442M |
| August 04, 2026 | 2.400M |
| August 03, 2026 | 2.423M |
| July 31, 2026 | 2.427M |
| July 30, 2026 | 2.392M |
| July 29, 2026 | 2.367M |
| July 28, 2026 | 2.187M |
| July 27, 2026 | 2.186M |
| Date | Value |
|---|---|
| July 24, 2026 | 2.158M |
| July 23, 2026 | 2.092M |
| July 22, 2026 | 2.032M |
| July 21, 2026 | 1.992M |
| July 20, 2026 | 1.872M |
| July 17, 2026 | 1.802M |
| July 16, 2026 | 1.771M |
| July 15, 2026 | 1.790M |
| July 14, 2026 | 1.794M |
| July 13, 2026 | 1.803M |
| July 10, 2026 | 1.843M |
| July 09, 2026 | 1.823M |
| July 08, 2026 | 1.820M |
| July 07, 2026 | 1.835M |
| July 06, 2026 | 1.864M |
| July 02, 2026 | 1.881M |
| July 01, 2026 | 1.875M |
| June 30, 2026 | 1.908M |
| June 29, 2026 | 1.986M |
| June 26, 2026 | 2.019M |
| June 25, 2026 | 1.936M |
| June 24, 2026 | 1.704M |
| June 23, 2026 | 1.682M |
| June 22, 2026 | 1.681M |
| June 18, 2026 | 1.644M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Passage Bio, Inc. | 19820.77 |
| Vertex Pharmaceuticals, Inc. | 1.235M |
| Capricor Therapeutics, Inc. | 10.83M |
| Kyntra Bio, Inc. | 11439.93 |
| Zentalis Pharmaceuticals, Inc. | 1.140M |